Chemoinformaics analysis of TRIHYDROXYSTEARIC-ACID
| Molecular Weight | 332.481 | nRot | 17 |
| Heavy Atom Molecular Weight | 296.193 | nRig | 1 |
| Exact Molecular Weight | 332.256 | nRing | 0 |
| Solubility: LogS | -3.718 | nHRing | 0 |
| Solubility: LogP | 5.741 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 58.0745 |
| nHD | 4 | BPOL | 36.9835 |
| QED | 0.239 |
| Synth | 2.187 |
| Natural Product Likeliness | 0.419 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.002 |
| HIA | 0.015 |
| CACO-2 | -5.393 |
| MDCK | 0.0000366 |
| BBB | 0.594 |
| PPB | 0.982411 |
| VDSS | 0.608 |
| FU | 0.0122581 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.109 |
| CYP2c19-inh | 0.043 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.165 |
| CYP2c9-sub | 0.963 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.034 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.013 |
| CL | 9.442 |
| T12 | 0.67 |
| hERG | 0.031 |
| Ames | 0.002 |
| ROA | 0.016 |
| SkinSen | 0.896 |
| Carcinogencity | 0.044 |
| EI | 0.967 |
| Respiratory | 0.703 |
| NR-Aromatase | 0.467 |
| Antiviral | Yes |
| Prediction | 0.782716 |